News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Invitrogen Corporation (IVGN) Wins Appeals Court Decision Against Stratagene


10/19/2005 5:13:21 PM

CARLSBAD, Calif.--(BUSINESS WIRE)--Oct. 13, 2005--Invitrogen Corporation, a leading life science company providing innovative technologies to support disease research, today announced a favorable decision in its patent infringement lawsuit against Stratagene, Inc. On appeal from a decision by the U.S. District Court for the Western District of Texas, the U.S. Court of Appeals for the Federal Circuit found that substantially all of the chemically competent cell products sold by Stratagene infringed Invitrogen's patent. In the decision, the Court of Appeals remanded the case to the district court for further proceedings.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES